Matches in Wikidata for { <http://www.wikidata.org/entity/Q79110677> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q79110677 description "clinical trial" @default.
- Q79110677 description "ensayu clínicu" @default.
- Q79110677 description "klinisch onderzoek" @default.
- Q79110677 description "клінічне випробування" @default.
- Q79110677 description "կլինիկական փորձարկում" @default.
- Q79110677 name "A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (an Autoimmune Disorder That Destructs Platelets, Blood Cells That Help With Clotting, and Can Lead to Easy or Excessive Bruising an" @default.
- Q79110677 name "A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (an Autoimmune Disorder That Destructs Platelets, Blood Cells That Help With Clotting, and Can Lead to Easy or Excessive Bruising an" @default.
- Q79110677 type Item @default.
- Q79110677 label "A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (an Autoimmune Disorder That Destructs Platelets, Blood Cells That Help With Clotting, and Can Lead to Easy or Excessive Bruising an" @default.
- Q79110677 label "A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (an Autoimmune Disorder That Destructs Platelets, Blood Cells That Help With Clotting, and Can Lead to Easy or Excessive Bruising an" @default.
- Q79110677 prefLabel "A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (an Autoimmune Disorder That Destructs Platelets, Blood Cells That Help With Clotting, and Can Lead to Easy or Excessive Bruising an" @default.
- Q79110677 prefLabel "A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (an Autoimmune Disorder That Destructs Platelets, Blood Cells That Help With Clotting, and Can Lead to Easy or Excessive Bruising an" @default.
- Q79110677 P1050 Q79110677-DE1F65BF-9B66-484D-A286-860DBE8CD5CB @default.
- Q79110677 P1132 Q79110677-3909059E-24CF-43FB-A830-95C2A5E602E7 @default.
- Q79110677 P1476 Q79110677-45BFF442-5722-414E-A697-862CC2C0B6F3 @default.
- Q79110677 P17 Q79110677-E5FD96FE-8AE0-4DB7-B1E5-5B4648628A90 @default.
- Q79110677 P1813 Q79110677-7F7C7079-42FB-471B-8AE9-0C2245C56D6C @default.
- Q79110677 P2899 Q79110677-9B3AF9A8-E240-4E2F-B8A4-80DA903C2190 @default.
- Q79110677 P3098 Q79110677-46159F6E-A7BF-40EE-BD54-1B6F434DD533 @default.
- Q79110677 P31 Q79110677-FE9AE191-6172-4DDE-BC7E-0659ED44E891 @default.
- Q79110677 P580 Q79110677-C05F8C78-EB0D-4E71-AC7E-1FB6F5133C57 @default.
- Q79110677 P582 Q79110677-910E363A-98C4-473A-8653-23BA3D365E14 @default.
- Q79110677 P6099 Q79110677-EF95E471-DCA8-4E70-8660-6B178C9704A9 @default.
- Q79110677 P8363 Q79110677-6604C304-3BCF-4233-A330-1AC8B21D7F2A @default.
- Q79110677 P1050 Q585285 @default.
- Q79110677 P1132 "+156" @default.
- Q79110677 P1476 "A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Efgartigimod (ARGX 113) 10 mg/kg Intravenous in Adult Patients With Primary Immune Thrombocytopenia" @default.
- Q79110677 P17 Q30 @default.
- Q79110677 P1813 "ADVANCE" @default.
- Q79110677 P2899 "+18" @default.
- Q79110677 P3098 "NCT04188379" @default.
- Q79110677 P31 Q30612 @default.
- Q79110677 P580 "2019-12-04T00:00:00Z" @default.
- Q79110677 P582 "2021-06-06T00:00:00Z" @default.
- Q79110677 P6099 Q42824827 @default.
- Q79110677 P8363 Q78089383 @default.